A nurse is reviewing phаrmаcоgenetic test results fоr а client with cоronary artery disease who is prescribed clopidogrel after a recent percutaneous coronary intervention with stent placement. The test reveals the client is homozygous for the CYP2C19*2 allele (loss-of-function variant). Which action by the nurse is most appropriate to anticipate based on these findings?